Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rituximab Cll'

Rituximab Cll published presentations and documents on DocSlides.

RituximabinIndolentLymphomasTarekSousouandJonathanFriedberg

RituximabinIndolentLymphomasTarekSousouandJonathanFriedberg

  • kittie-lecroy
  • 10 Slides

Indolentnon-Hodgkinlymphoma(NHL)comprisesagroupofi...

Mantelcell

Mantelcell

  • tawny-fly
  • 44 Slides

. lymfom. Från. indolent till aggressive . sju...

Chronic lymphocytic leukemia,

Chronic lymphocytic leukemia,

  • natalia-silvester
  • 31 Slides

New agents timing?. Agne Paner, MD. Assistant pro...

Update on Follicular Lymphoma:

Update on Follicular Lymphoma:

  • alexa-scheidler
  • 259 Slides

Contemporary Treatment Strategies and Optimal Seq...

Update on Follicular Lymphoma:

Update on Follicular Lymphoma:

  • tatiana-dople
  • 254 Slides

Contemporary Treatment Strategies and Optimal Seq...

HIV and Non Hodgkin Lymphoma

HIV and Non Hodgkin Lymphoma

  • karlyn-bohler
  • 27 Slides

Virginia C. . Broudy. , MD. September 25, 2014. P...

Integration of Novel Therapies in WM and CLL : When and How

Integration of Novel Therapies in WM and CLL : When and How

  • giovanna-bartolotta
  • 55 Slides

Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

  • luanne-stotts
  • 66 Slides

Moderator. Neil Love, MD. Mollie Moran, MSN, CNP,...

New Perspectives in Treatment Strategies for Follicular Lymphoma

New Perspectives in Treatment Strategies for Follicular Lymphoma

  • olivia-moreira
  • 0 Slides

Introduction. Standard Frontline Therapy for FL. ...

A Closer Look at Pemphigus Vulgaris: Clinical Challenges and

A Closer Look at Pemphigus Vulgaris: Clinical Challenges and

  • celsa-spraggs
  • 0 Slides

Emerging Treatments . Description of Program. Thi...

Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)

Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)

  • ellena-manuel
  • 0 Slides

Swiss Group for Clinical Cancer Research (SAKK). ...

Indolent Lymphomas Dr. Melissa Toupin

Indolent Lymphomas Dr. Melissa Toupin

  • liane-varnes
  • 0 Slides

The Ottawa Hospital. What does indolent mean?. Sl...

Indolent Non-Hodgkin L

Indolent Non-Hodgkin L

  • danika-pritchard
  • 0 Slides

ymphoma. Sobia Ozair. March 8, 2017. MD Anderson ...

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

  • conchita-marotz
  • 0 Slides

ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....

Updates in Lymphoma From Recent Congresses

Updates in Lymphoma From Recent Congresses

  • lindy-dunigan
  • 0 Slides

Therapeutic Targets in CLL. Venetoclax in Patient...

Understanding Biologics Biologics and Biosimilars

Understanding Biologics Biologics and Biosimilars

  • calandra-battersby
  • 0 Slides

Animation: What Are Biologics?. Production of Bio...

Applying Biosimilars in Hematologic Cancers

Applying Biosimilars in Hematologic Cancers

  • conchita-marotz
  • 0 Slides

This program will include a discussion of off-lab...

Overall Survival Benefit of

Overall Survival Benefit of

  • tatyana-admore
  • 123 Slides

Obinutuzumab. Over Rituximab when Combined with ...

Drug Treatment of Hematopoietic Malignancy

Drug Treatment of Hematopoietic Malignancy

  • mitsue-stanley
  • 14 Slides

Munir Gharaibeh, MD, PhD, MHPE. Department of Pha...

Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?

Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?

  • mitsue-stanley
  • 25 Slides

Bertrand Coiffier. Service d. ’. Hématologie. ...

Carfilzomib , Rituximab and Dexamethasone (

Carfilzomib , Rituximab and Dexamethasone (

  • mindeeli
  • 10 Slides

CaRD. ) Is Highly . Active and . Offers a Neuropat...

A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K

A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K

  • windbey
  • 10 Slides

δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...

Mature Results from ECOG Study E1405 — A Phase II Study of

Mature Results from ECOG Study E1405 — A Phase II Study of

  • webraph
  • 11 Slides

VcR. -CVAD with Maintenance Rituximab for Previous...

Cheson B et al. Proc ASH

Cheson B et al. Proc ASH

  • pattyhope
  • 49 Slides

2016;Abstract 615; Sehn LH. et al. . Lancet . Onc...

Part B Medical Drugs Requiring Step

Part B Medical Drugs Requiring Step

  • udeline
  • 1 Slides

-TherapyDrug subject to Step TherapyTry these Opti...

Part B Medical Drugs Requiring StepTherapy

Part B Medical Drugs Requiring StepTherapy

  • natalie
  • 1 Slides

Drug subject to Step Therapy BRAND NAME GENERIC NA...

MEDICATION GUIDE

MEDICATION GUIDE

  • audrey
  • 3 Slides

ZYDELIGzyeDELigidelalisibtabletsWhat is the most i...

Antibody-based Therapies

Antibody-based Therapies

  • osullivan
  • 37 Slides

Dr. John Kuruvilla. Princess Margaret Cancer Centr...

PAPS Bled with Anti-coagulation, Infected with Immunosuppression and Ineffective IVIG,

PAPS Bled with Anti-coagulation, Infected with Immunosuppression and Ineffective IVIG,

  • stella
  • 21 Slides

What’s Next?. Abo Baker . Ahmd. . Mosa. , MD. U...

Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma

Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma

  • isabella2
  • 42 Slides

Dr. Gilles SALLES. Chief . of. . the. . Lymphoma...

Thyroid eye disease B.Eshraghi

Thyroid eye disease B.Eshraghi

  • brown
  • 65 Slides

M.D. Associate professor of ophthalmology. Ophthal...

Patients with total IgG <400 mg/dL while receiving rituximab should

Patients with total IgG <400 mg/dL while receiving rituximab should

  • ivy
  • 35 Slides

NOT. receive IgG replacement therapy. . AAIFNC F...

Published in nejm in sep 2016

Published in nejm in sep 2016

  • Wildboyz
  • 24 Slides

RITUXIMAB IN B-LINEAGE ADULT ACUTE LYMPHOBLASTIC L...

In the name of god brief review on

In the name of god brief review on

  • SugarAndSpice
  • 42 Slides

nhl. Presenting by . F.Malek. M.D. Assistant Prof...

Paolo Ghia, 1 Andrzej Pluta,

Paolo Ghia, 1 Andrzej Pluta,

  • HappyHippo
  • 9 Slides

2. Malgorzata Wach,. 3. Daniel Lysak,. 4. Tomas...

Module 3: Chronic Lymphocytic Leukemia

Module 3: Chronic Lymphocytic Leukemia

  • CottonTails
  • 26 Slides

Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...

Practice Guidelines

Practice Guidelines

  • roy
  • 9 Slides

Clinical Haematology, University Hospital Liège a...

266 Cancer Control

266 Cancer Control

  • iris
  • 13 Slides

Gum Drop Mushrooms . Photograph courtesy of Sherri...

BC Cancer Protocol Summary LYCHOPRMTXPage of

BC Cancer Protocol Summary LYCHOPRMTXPage of

  • melody
  • 10 Slides

Activated: 1 Jun 2014 Revised: Mar 2022tests rev...

rials as treatment options for eligible patients

rials as treatment options for eligible patients

  • elysha
  • 13 Slides

Page 1 of 13 Note : Consider C linical T . Wa...

Copyright © 2024 DocSlides. All Rights Reserved